Phenolphthalein API Manufacturers

Looking for Phenolphthalein API 77-09-8?

Description:

Here you will find a list of producers, manufacturers and distributors of Phenolphthalein. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Phenolphthalein 

Synonyms:

Fenolftalein , Fenolftaleina , Phenolphtaleine , Phenolphthaleinum , Phenophthalein  

Cas Number:

77-09-8 

DrugBank number:

DB04824 

Unique Ingredient Identifier:

6QK969R2IF

Phenolphthalein is a type of Laxatives

Laxatives are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that are commonly used to promote bowel movements and alleviate constipation. These medications are designed to stimulate the digestive system, facilitating the passage of stool and providing relief to individuals experiencing irregular or infrequent bowel movements.

Laxatives work through various mechanisms, including increasing intestinal motility, softening stool consistency, or promoting water retention in the intestines. They are available in different forms, such as tablets, capsules, powders, or liquids, catering to diverse patient preferences and requirements.

There are several types of laxatives, each with its unique mode of action. Bulk-forming laxatives contain fiber or other indigestible substances that absorb water, adding bulk to the stool and promoting regular bowel movements. Stimulant laxatives, on the other hand, stimulate the intestinal muscles, accelerating the passage of stool through the intestines. Osmotic laxatives draw water into the intestines, softening the stool and facilitating its movement. Additionally, stool softeners and lubricant laxatives can help ease bowel movements by making the stool easier to pass.

Laxatives are commonly used for short-term relief from constipation or to prepare for certain medical procedures or surgeries. However, their long-term use should be done under the guidance of healthcare professionals to prevent dependency or potential adverse effects.

In conclusion, laxatives are a vital subcategory of pharmaceutical APIs that aid in managing constipation and improving bowel regularity. They are available in various formulations and function through different mechanisms to provide effective relief. However, it is crucial to use laxatives responsibly and seek professional advice when necessary.

Phenolphthalein (Laxatives), classified under Gastrointestinal Agents

Gastrointestinal Agents belong to the pharmaceutical API category that focuses on treating disorders and ailments related to the digestive system. These agents play a crucial role in addressing various gastrointestinal conditions, such as acid reflux, ulcers, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD).

One of the key types of gastrointestinal agents is proton pump inhibitors (PPIs), which work by reducing the production of stomach acid. PPIs help in treating conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. Another essential class of agents is antacids, which neutralize excessive stomach acid, providing relief from heartburn and indigestion.

Gastrointestinal agents also include antispasmodics that alleviate abdominal cramps and spasms associated with conditions like IBS. These drugs work by relaxing the smooth muscles of the digestive tract. Additionally, there are drugs categorized as laxatives that aid in relieving constipation by promoting bowel movements.

Moreover, certain gastrointestinal agents act as antiemetics, effectively reducing nausea and vomiting. These drugs are particularly useful for patients undergoing chemotherapy or experiencing motion sickness.

Pharmaceutical companies develop and manufacture a wide range of gastrointestinal agents in various forms, including tablets, capsules, suspensions, and injections. These agents are typically formulated using active pharmaceutical ingredients (APIs) and other excipients to ensure their efficacy and safety.

In conclusion, gastrointestinal agents form a vital category of pharmaceutical APIs, providing relief from digestive disorders and improving overall gastrointestinal health. The availability of diverse agents catering to different conditions ensures that patients can receive targeted treatment for their specific gastrointestinal needs.